Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph early_phase_1

20%

Ph not_applicable

60%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (20.0%)

Phase 21 (20.0%)

N/A3 (60.0%)

Trials by Status

completed480%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity

NCT00454597

Clinical Trials (5)

Showing 5 of 5 trials

NCT00212160Not Applicable

The Role of the Omentum in the Treatment of Morbid Obesity

Completed

NCT00565799Phase 2

A Pilot Study of Metabolic Effects of Omentectomy

Terminated

NCT01785134Not Applicable

Effects of Different Surgical Methods to Treat Obesity

Completed

NCT00923260Not Applicable

Omentectomy and Metabolic Syndrome

Completed

NCT00454597Early Phase 1

Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5